BioCentury | May 6, 2013
Regulation

The patient voice

...with CFS in 1996 after a tropical illness, said "particularly helpful" treatments included Valtrex valacyclovir, famciclovir...
...is a viral polymerase inhibitor marketed by GlaxoSmithKline plc to treat cytomegalovirus (CMV) infection. Famvir famciclovir...
BioCentury | Feb 13, 2012
Clinical News

Famvir famciclovir regulatory update

...Asahi Kasei submitted a regulatory application in Japan to expand the label of Famvir famciclovir to...
...Kasei, which has Japanese rights to Famvir from Novartis under a 2008 deal, jointly developed Famvir...
...Asahi Kasei Pharma Corp. , Tokyo, Japan Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Product: Famvir famciclovir...
BioCentury | Feb 22, 2010
Company News

Teva, Novartis infectious news

...herpes drug Famvir famciclovir. Novartis also is eligible for royalties on U.S. sales of generic famciclovir...
BioCentury | May 25, 2009
Product Development

Shackling shingle's pain

...inhibitors most commonly used to treat shingles are Valtrex valacyclovir from GlaxoSmithKline plc ; Famvir famciclovir...
...understood, Plumb said FV-100 is 10,000 times more potent in vitro than either Valtrex or Famvir...
...took somewhere between 2-3 days of exposure, at much higher concentrations, for both Valtrex and Famvir...
BioCentury | Sep 25, 2008
Distillery Therapeutics

This Week in Therapeutics

...Zovirax acyclovir, two nucleoside analogs from GlaxoSmithKline plc, are marketed to treat HSV infection. Famvir famciclovir...
BioCentury | Oct 9, 2006
Company News

Tap Pharmaceutical, Novartis sales and marketing update

...The companies will co-promote NVS's herpes drug Famvir famciclovir in the U.S. Tap will be responsible...
BioCentury | Aug 7, 2006
Clinical News

Famvir famciclovir regulatory update

...FDA approved an sNDA for Famvir as a single-dose treatment for recurrent herpes labialis (cold sores...
...recurrent herpes labialis (cold sores) in immunocompetent patients. The agency also approved an sNDA for Famvir...
...mucocutaneous herpes simplex infections in HIV-infected patients. Novartis AG (NVS; SWX:NOVN), Basel, Switzerland Product: Famvir famciclovir...
BioCentury | Jun 12, 2006
Strategy

Infectious space at Novartis

...Meningococcal vaccines [Chiron acq] Pediatric vaccines [Chiron acq] Travel vaccines [Chiron acq] Coartem/Riamet for malaria Famvir...
BioCentury | Jan 2, 2006
Clinical News

Famvir famciclovir infectious data

...study in 329 patients with recurrent genital herpes showed that a single day treatment of Famvir...
...outbreak, significantly stopped progression to full outbreak and shortened the duration of outbreak vs. placebo. Famvir...
...Antimicrobial Agents and Chemotherapy meeting in Washington. Novartis AG (NVS; SWX:NOVN), Basel, Switzerland Product: Famvir famciclovir...
BioCentury | Sep 5, 2005
Strategy

Novartis infectious disease deals

...bacteria for NVS 2000 SmithKline Beecham (now GlaxoSmithKline) $1.6B NVS pays $1.6B to acquire SmithKline's Famvir...
Items per page:
1 - 10 of 23